Form 8-K - Current report:
SEC Accession No. 0001104659-25-098998
Filing Date
2025-10-14
Accepted
2025-10-14 07:12:43
Documents
27
Period of Report
2025-10-14
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.02: Results of Operations and Financial Condition
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm2528677d1_8k.htm   iXBRL 8-K 71027
2 EXHIBIT 2.1 tm2528677d1_ex2-1.htm EX-2.1 801357
3 EXHIBIT 99.1 tm2528677d1_ex99-1.htm EX-99.1 84733
4 EXHIBIT 99.2 tm2528677d1_ex99-2.htm EX-99.2 36099
5 EXHIBIT 99.3 tm2528677d1_ex99-3.htm EX-99.3 22649
9 GRAPHIC tm2528677d1_ex99-3img001.jpg GRAPHIC 100555
10 GRAPHIC tm2528677d1_ex99-3img002.jpg GRAPHIC 284025
11 GRAPHIC tm2528677d1_ex99-3img003.jpg GRAPHIC 288845
12 GRAPHIC tm2528677d1_ex99-3img004.jpg GRAPHIC 176397
13 GRAPHIC tm2528677d1_ex99-3img005.jpg GRAPHIC 170451
14 GRAPHIC tm2528677d1_ex99-3img006.jpg GRAPHIC 121220
15 GRAPHIC tm2528677d1_ex99-3img007.jpg GRAPHIC 170455
16 GRAPHIC tm2528677d1_ex99-3img008.jpg GRAPHIC 102618
17 GRAPHIC tm2528677d1_ex99-3img009.jpg GRAPHIC 132700
18 GRAPHIC tm2528677d1_ex99-3img010.jpg GRAPHIC 145991
19 GRAPHIC tm2528677d1_ex99-3img011.jpg GRAPHIC 34554
  Complete submission text file 0001104659-25-098998.txt   3786329

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA atxs-20251014.xsd EX-101.SCH 3017
7 XBRL TAXONOMY EXTENSION LABEL LINKBASE atxs-20251014_lab.xml EX-101.LAB 34239
8 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE atxs-20251014_pre.xml EX-101.PRE 22360
29 EXTRACTED XBRL INSTANCE DOCUMENT tm2528677d1_8k_htm.xml XML 3685
Mailing Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210
Business Address 22 BOSTON WHARF ROAD 10TH FLOOR BOSTON MA 02210 617-349-1971
Astria Therapeutics, Inc. (Filer) CIK: 0001454789 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-37467 | Film No.: 251389599
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)